Leidos Holdings - LDOS STOCK NEWS

Leidos (NYSE: LDOS) will participate in the Bernstein 38th Annual Strategic Decisions Conference on June 1, 2022, from 2:30 p.m. to 3:20 p.m. ET. CEO Roger Krone will engage in a 'fireside chat' during the event. A live audio webcast of the conference will be accessible on the Leidos Investor Relations website at ir.leidos.com. A replay will be available for one year after the event. Leidos, headquartered in Reston, Virginia, reported annual revenues of approximately $13.7 billion for FY 2021.

Leidos (NYSE: LDOS) has been awarded two contracts valued at $90M by NATO to enhance its ballistic missile defense capabilities. Each contract spans four years with options for four additional maintenance years. The company, with over 20 years of NATO partnership experience, will lead a team to develop NATO's BMD Architecture, C2 systems, and maintain the BMD Integration Test Bed. Leidos reported revenues of approximately $13.7 billion for FY 2021. This contract reflects the company's ongoing commitment to national defense and positions it favorably in the defense sector.

Leidos Holdings (LDOS) reported a robust Q1 2022 with revenues of $3.5 billion, up 5% year-over-year. Net income was $177 million with diluted EPS of $1.25, reflecting a 14% decline from the previous year due to prior adjustments. Adjusted EBITDA fell to $358 million, down 8%. Notably, net bookings reached $5.4 billion, resulting in a record backlog of $36.3 billion. Leidos maintains its full-year guidance, expecting revenues between $13.9 billion and $14.3 billion.

Leidos (NYSE: LDOS), a FORTUNE 500 company, will participate in the Goldman Sachs Industrials and Materials Conference on May 10, 2022, from 9:40 a.m. to 10:15 a.m. ET. CFO Chris Cage will take part in a fireside chat during this event held in New York, NY. A live audio webcast will be available on their Investor Relations website, with a replay accessible for one year. Leidos, headquartered in Reston, Virginia, reported annual revenues of approximately $13.7 billion for the fiscal year ending December 31, 2021.

Leidos Holdings, Inc. (NYSE:LDOS) has declared a quarterly cash dividend of $0.36 per share, payable on June 30, 2022, to stockholders of record as of June 15, 2022. The announcement reflects the company's commitment to returning value to its shareholders. Leidos, a leader in technology and engineering solutions, reported annual revenues of approximately $13.7 billion for the fiscal year ending December 31, 2021, with 43,000 employees supporting vital missions across various sectors.

Leidos (NYSE: LDOS) has commenced construction on a new facility at Campus Point in San Diego, California, expected to be completed by mid-2024. This state-of-the-art building will enhance corporate real estate efficiency for employees and customers, hosting over 400 staff with secure spaces for classified programs. The project, developed by Alexandria Real Estate Equities, focuses on advancing technologies at the Leidos Innovations Center. Additionally, Leidos announced a $25,000 contribution to the Salvation Army, supporting the local community.

Leidos (NYSE: LDOS) has announced a conference call on May 3, 2022, at 8 a.m. ET to discuss its financial results for the first quarter ending April 1, 2022. A press release detailing quarterly earnings will be issued prior to the call. Investors can access the call via the internet or telephone, with replay options available after the event. Leidos reported approximately $13.7 billion in annual revenues for 2021 and operates across defense, intelligence, civil, and health markets.

Leidos (NYSE:LDOS) announced the appointment of Steve Cook as Dynetics Group President, effective April 1. Paul Engola will serve as Deputy Group President. Cook, previously the deputy group president and operations manager, has extensive experience in space technologies and led various projects at NASA. The leadership transition aims to enhance the company’s presence in the national security space market. Dave King will remain as a consultant during the transition, ensuring continuity in strategic initiatives.

The Leidos Partnership for Defense Health (LPDH) announced the successful deployment of the MHS GENESIS electronic health record system to 15,000 clinicians across 14 Military Treatment Facility Commands in five states. This marks the largest double Wave deployment to date, expanding the system's operational capacity to 1,360 locations with over 92,000 active users. The project remains on schedule and within budget, with nine additional deployments planned through the end of 2023, aiming for full implementation by year-end.